IPOs 2014: Coupons.com

IPO Coupons.com (COUP) operates a digital promotion platform that connects brands and retailers with consumers. They deliver digital coupons to consumers and display advertising through web, mobile and social channels.

Get an advisory report for this company's Initial Public Offering
View this company's prospectus

IPOs 2014: Varonis

IPO Varonis Systems Inc. (VRNS) provides a software platform that allows enterprises to map, analyze, manage and migrate unstructured data created by employees. IT and business personnel deploy this software for data governance and security, archiving, file synchronization, mobile data accessibility and information collaboration.

Get an advisory report for this company's Initial Public Offering
View this company's prospectus

IPOs 2014: Revance

IPO Revance Therapeutics Inc. (RVNC) is a clinical stage specialty biopharmaceutical company focused on the development, manufacturing and commercialization of novel botulinum toxin products. Revance owns the worldwide rights to both product candidates.

Get an advisory report for this company's Initial Public Offering
View this company's prospectus

IPOs 2014: uniQure

IPO uniQure (QURE) has developed the first and currently the only gene therapy product to receive regulatory approval in the European Union. Their first product, Glybera, was approved by the European Commission in October 2012 for the treatment of a subset of patients with lipoprotein lipase deficiency, or LPLD. UniQure expects to launch Glybera commercially in selected European countries in the first half of 2014 through their collaboration with Chiesi Farmaceutici S.p.A.

Get an advisory report for this company's Initial Public Offering
View this company's prospectus